Key facts
- This page summarizes Patrick Bilbo's Form 4 filing for Organogenesis Holdings Inc. (ORGO).
- 4 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 20 Feb 2026, 17:28.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Award
Tax liability
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Represents a grant of restricted stock units ("RSUs") under the Organogenesis Holdings Inc. ("Organogenesis") 2018 Equity Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of Organogenesis Class A common stock. The RSUs vest in equal annual installments over four years beginning February 15, 2026.
Footnote F2
Shares issued pursuant to the vesting and settlement of a performance share award granted in 2025 based on the achievement of certain performance milestones.
Footnote F3
The option becomes exercisable in equal annual installments over four years beginning February 15, 2026.